The Challenge of PrEP Adherence

Pre-exposure prophylaxis (PrEP) is a highly effective method for preventing HIV, but consistent adherence is crucial for it too work. This is particularly challenging within the transgender community, where adherence rates have historically lagged behind other populations. According to the Centers for Disease Control and Prevention (CDC), in 2019, 671 of the⁤ 36,801 HIV diagnoses in the US were among transgender individuals ², highlighting the need for targeted interventions.

Despite a high level of awareness – with 92% of transgender women without HIV knowing about PrEP – only 32% were actually using it. This gap underscores the barriers to access and consistent use, prompting researchers to explore ‍strategies to ⁣improve adherence.

A new study Reveals Key Incentives

Recent research published in Medical Decision Making ¹ investigated the impact of various incentives on PrEP adherence‍ among transgender and nonbinary adults in Washington state. The study, conducted⁤ through the Washington Priority Assessment in Trans Health project,⁤ utilized a⁣ discrete-choice experiment to determine which factors most strongly motivated consistent use of⁢ long-acting injectable PrEP (LA-PrEP).

385 participants,with an average age of 29,were surveyed about their preferences regarding incentives. The majority (62.9%) identified as White, and over 99% had health insurance. Though, a significant portion (79.2%) had not previously taken prep, and more than half reported⁤ an annual income under $50,000.

What Motivates Consistent PrEP Use?

The findings revealed several key factors influencing adherence:

• Yearly Incentives: Participants responded positively to the prospect of annual ⁤financial⁢ incentives, with increased incentive amounts directly correlating to a higher likelihood of choosing an intervention program.
• Payment Method: Electronic cash cards were the preferred method for receiving incentives.
• Hormone Therapy: ‍ Offering a coprescription for injectable hormones during LA-PrEP visits was highly valued, exceeding the preference⁣ for oral hormones or no prescription at all. Participants were willing to forgo $547 to receive this coprescription.
• Testing & Counseling: Participants preferred blood testing to confirm adherence and in-person counseling.

The study steadfast a maximum yearly incentive amount of $1200 was appealing. Participants valued blood testing for adherence confirmation at ⁤$112 and ⁢preferred cash incentives over vouchers by $689.

Targeting ‍Interventions for Maximum Impact

Interestingly, the study found that⁣ the effectiveness of thes incentives varied by age and income. Programs offering incentives⁣ for both gender-affirming care⁤ and LA-PrEP were most appealing to younger‍ adults (45% probability of being chosen),⁣ with that ⁤probability decreasing among older individuals and those with higher incomes. This suggests that interventions should be specifically tailored to the needs of younger, less economically stable transgender individuals.

Limitations and Future Research

Researchers acknowledge some limitations to the study. The participant pool was primarily White and located in the Pacific Northwest, possibly limiting the generalizability of the findings. Additionally, the‍ study relied ⁣on self-reported preferences, and further research, including randomized controlled trials, is needed to confirm⁤ these results and assess the long-term impact of these interventions.